Here’s a roundup of the latest coronavirus-related news.
This week marked 500,000 coronavirus-related deaths in the United States. The COVID-19 vaccination effort is well underway in the US, with over 68.27 million administered doses and 6.8% of the population fully vaccinated against the virus as of press time.
This week, an FDA advisory board confirmed the safety and efficacy of Johnson & Johnson’s COVID-19 vaccine candidate, and experts weigh in on how pharmacists can effectively tackle vaccination programs.
Here’s a roundup of the latest coronavirus-related news:
FDA Panel Endorses Johnson & Johnson's COVID-19 Vaccine for EUA
On Friday, a panel of advisors to the FDA voted to recommend Johnson & Johnson's COVID-19 vaccine, named Ad26.COV2.S, for emergency approval.
The Impact of COVID-19 on Pharmacy Management and Compliance
Pharmacy leaders have leveraged their experience, their role in interdisciplinary teams, and technology to quickly reinvent approaches to manage long-standing issues exacerbated by the pandemic.
FDA Analysis of Johnson & Johnson COVID-19 Vaccine Confirms Safety, Efficacy
On Wednesday, the FDA released results of an analysis for Johnson & Johnson’s COVID-19 vaccine candidate that supports its authorization for emergency use.
Regulation and Cost Considerations for Pharmacists Administering COVID-19 Vaccines
In our final interview segment, Lee Rosebush dives into improving vaccine distribution, addressing costs, and maintaining records while vaccinating for COVID-19.
Part 2: Pharmacist Leads COVID-19 Vaccination Clinic
In part 2 of our interview, Kaitlyn Rivard, PharmD, leads an insightful discussion on the practical side of administering COVID-19 vaccines.
MJH COVID-19 Coalition Provides Perspectives on Vaccine Rollout, Double Masking
Members of the MJH Life Sciences™ COVID-19 Coalition recently weighed in on the latest COVID-19 pandemic news.
Avoid Regulation Issues With This State-By-State COVID-19 Vaccination Guide
Lee Rosebush of BakerHostetler law firm discussed how pharmacies can avoid regulatory and compliance issues amid their COVID-19 vaccination programs.
AAP letter urges the start of COVID-19 vaccine trials in young children
A safe COVID-19 vaccine that can be administered to most of the pediatric population is a necessity for ending the pandemic, but trials for younger children have not occurred. The president of the American Academy of Pediatrics (AAP) wrote to key COVID-19 officials about the need to change this.
2 Clarke Drive
Cranbury, NJ 08512